AKYA
Income statement / Annual
Last year (2023), Akoya Biosciences, Inc.'s total revenue was $96.63 M,
an increase of 29.09% from the previous year.
In 2023, Akoya Biosciences, Inc.'s net income was -$63.32 M.
See Akoya Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$96.63 M
|
$74.86 M
|
$54.92 M
|
$42.44 M
|
$42.24 M
|
| Cost of Revenue |
$48.40 M |
$31.47 M |
$20.70 M |
$16.54 M |
$17.57 M |
| Gross Profit |
$48.24 M |
$43.39 M |
$34.22 M |
$25.91 M |
$24.66 M |
| Gross Profit Ratio |
0.5 |
0.58 |
0.62 |
0.61 |
0.58 |
| Research and Development
Expenses |
$21.89 M
|
$23.21 M
|
$15.70 M
|
$9.60 M
|
$8.76 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$25.45 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$900,000.00
|
| Selling, General &
Administrative Expenses |
$82.38 M
|
$79.65 M
|
$51.02 M
|
$23.98 M
|
$26.35 M
|
| Other Expenses |
-$343,000.00 |
$6.73 M |
$4.73 M |
$3.82 M |
$3.06 M |
| Operating Expenses |
$104.27 M |
$109.60 M |
$71.44 M |
$37.40 M |
$38.17 M |
| Cost And Expenses |
$152.67 M |
$141.07 M |
$92.14 M |
$53.94 M |
$55.74 M |
| Interest Income |
$3.49 M |
$777,000.00 |
$91,000.00 |
$2.72 M |
$1.88 M |
| Interest Expense |
$8.76 M |
$4.55 M |
$3.12 M |
$2.72 M |
$1.88 M |
| Depreciation &
Amortization |
$8.89 M
|
$7.15 M
|
$4.79 M
|
$3.82 M
|
$3.06 M
|
| EBITDA |
-$47.14 M
|
-$59.33 M
|
-$32.91 M
|
-$7.64 M
|
-$10.82 M
|
| EBITDA Ratio |
-0.49 |
-0.79 |
-0.6 |
-0.18 |
-0.26 |
| Operating Income Ratio
|
-0.58
|
-0.88
|
-0.68
|
-0.27
|
-0.32
|
| Total Other
Income/Expenses Net |
-$7.25 M
|
-$4.31 M
|
-$5.85 M
|
-$5.17 M
|
-$1.05 M
|
| Income Before Tax |
-$63.28 M |
-$70.52 M |
-$43.08 M |
-$16.66 M |
-$14.56 M |
| Income Before Tax Ratio
|
-0.65
|
-0.94
|
-0.78
|
-0.39
|
-0.34
|
| Income Tax Expense |
$40,000.00 |
$123,000.00 |
-$140,000.00 |
$42,000.00 |
$194,000.00 |
| Net Income |
-$63.32 M |
-$70.64 M |
-$42.94 M |
-$16.71 M |
-$14.75 M |
| Net Income Ratio |
-0.66 |
-0.94 |
-0.78 |
-0.39 |
-0.35 |
| EPS |
-1.43 |
-1.87 |
-1.15 |
-0.45 |
-0.4 |
| EPS Diluted |
-1.43 |
-1.87 |
-1.15 |
-0.45 |
-0.4 |
| Weighted Average Shares
Out |
$44.43 M
|
$37.75 M
|
$37.42 M
|
$37.11 M
|
$37.11 M
|
| Weighted Average Shares
Out Diluted |
$44.43 M
|
$37.75 M
|
$37.42 M
|
$37.11 M
|
$37.11 M
|
| Link |
|
|
|
|
|
